Metabolic Health

The Control System Beneath Chronic Disease

ing metabolic flexibility and protecting long-term performance

The goal is not merely normal blood sugar. It is a body that can use, store and release energy at the right time, with the least hormonal strain.

Executive Summary

Metabolic health is the body’s ability to manage energy without repeatedly forcing glucose, insulin, fats, blood pressure and inflammation outside a healthy range. When this control system weakens, the body often compensates for years before routine glucose tests become abnormal.

The earliest problem is commonly insulin resistance: cells respond less effectively to insulin, while the pancreas releases more insulin to maintain control. This compensation can preserve normal glucose for a long time. Therefore, “normal blood sugar” does not always mean normal metabolism.

The practical message is simple. Do not wait for diabetes. Look earlier, connect the pattern and act on the main drivers: excess refined carbohydrate exposure, frequent eating, central fat gain, low muscle demand, poor sleep, chronic stress, inflammation, unsuitable medication effects and individual susceptibility.

THE CORE MODEL 1. Insulin resistance is both a weak cellular response and, usually, a state of excess insulin demand. 2. Fat tissue, liver and muscle can become resistant at different times and for different reasons. 3. Glucose may rise late; waist, triglycerides, blood pressure, liver fat and fasting insulin can change earlier. 4. Food quality matters, but timing, dose, movement, sleep, stress and muscle mass determine the response. 5. The best plan reduces metabolic pressure while preserving protein, strength, nutrient density and adherence.

This white paper provides a clear model for assessment and coaching. It uses insulin resistance as an organising lens within a wider clinical picture.

Key insights

1. Insulin is not simply a “blood sugar hormone.” It directs fuel storage, fat release, protein turnover, liver output, vascular function and signals across many tissues.
2. Chronic high insulin can be both a response to insulin resistance and a force that helps sustain it.
3. Visceral fat—the fat around internal organs—is more metabolically disruptive than fat stored safely under the skin.
4. Muscle is a major glucose sink. Strength, regular movement and adequate protein increase the body’s capacity to handle fuel.
5. Carbohydrate reduction can be highly effective for people with impaired glucose control, but the degree should be personalised and medication must be managed safely.
6. Sleep loss, stress hormones and inflammation can worsen insulin action even when diet appears disciplined.
7. The most useful outcome is not weight loss alone. It is better energy control, lower central fat, stronger muscle, improved markers and a plan the person can sustain.

1. Metabolic Health: What We Are Really Measuring

Metabolism is the continuous work of turning food and stored fuel into energy, structure and repair. Metabolic health means this system changes direction smoothly. After eating, the body can store nutrients. Between meals and overnight, it can release stored fuel. During exercise, it can increase demand. During recovery, it can rebuild.

This ability to change fuel sources is called metabolic flexibility. In simple terms, the body can use both glucose and fat without becoming trapped in one state.

A control-system view

Think of metabolism as an executive control system with five linked jobs:

1. Sense incoming fuel.
2. Decide whether to burn, store or build.
3. Move fuel into the correct tissue.
4. Release stored fuel when needed.
5. Prevent excessive swings that damage organs.

Insulin is one of the system’s main instructions. It rises after food, especially carbohydrate and mixed meals. It tells the body that fuel is available. Broadly, it promotes storage and restrains the release of stored fat. This is normal and essential. The problem is not insulin itself. The problem is needing too much insulin too often, or needing progressively more insulin to achieve the same result.

Why glucose can mislead

The pancreas can compensate for weakening insulin action by releasing more insulin. As a result, fasting glucose and HbA1c may remain normal while metabolic strain is already rising. HbA1c estimates average glucose over roughly three months, but it can be distorted by red-cell lifespan, iron status, kidney function and other factors. Therefore, it is useful, but it is not a complete metabolic assessment.

The progression often looks like this:

Stage	What is happening	What may still look normal	Clues that may appear
1. Compensation	Insulin demand rises to hold glucose steady.	Fasting glucose and HbA1c.	Higher fasting insulin, hunger, energy swings.
2. Spillover	Fat cells release more fatty acids; liver and muscle handling worsens.	Single glucose readings.	Waist gain, higher triglycerides, fatty liver.
3. Glycaemic drift	The pancreas can no longer fully compensate.	Some fasting readings.	Larger post-meal rises, prediabetes-range markers.
4. Failure of control	Glucose remains chronically high and organ risk rises.	Few routine markers.	Type 2 diabetes and complications.

Practical implication

Do not chase a single number. Follow the pattern. A person may have normal glucose yet show rising waist size, high triglycerides, low HDL cholesterol, elevated blood pressure, fatty liver, disrupted sleep and strong post-meal fatigue. Together, these clues can show a system working too hard to appear normal.

2. Insulin Resistance: The Two-Part Problem

Insulin resistance means a cell or tissue responds less effectively to insulin. However, at whole-body level,  that weak response usually travels with hyperinsulinaemia—persistently higher insulin than the body should need.

This creates a two-part problem:

1. The signal is weaker: insulin does not produce the same response in resistant tissues.
2. The signal is louder: the pancreas releases more insulin to force the response.

At first, the louder signal works. Later, it becomes part of the burden. The body is not simply failing to make enough insulin. It is often spending years making extra insulin to preserve glucose control.

Why tissues behave differently

The body does not become uniformly insulin resistant. Fat tissue, liver, muscle, blood vessels, brain and reproductive tissues can respond differently. This helps explain why insulin resistance can present as different conditions in different people.

Tissue	What insulin normally helps regulate	What resistance may contribute to
Fat tissue	Storage of incoming energy and restraint of fat release.	Larger fat cells, excess fatty-acid release and inflammation.
Liver	Control of glucose production and fat processing.	High fasting glucose, high triglycerides and fatty liver.
Muscle	Glucose uptake and fuel use during activity.	Larger post-meal glucose rises and lower exercise capacity.
Blood vessels	Nitric-oxide signalling, blood flow and vascular balance.	Higher pressure and impaired vessel function.
Ovaries and testes	Reproductive hormone signalling and energy balance.	Cycle disruption, androgen excess or erectile dysfunction in susceptible people.
Brain	Energy sensing, appetite and signalling.	Altered hunger, reward and possibly impaired brain energy handling.

Cause, consequence or both?

Insulin resistance has no single cause. However, several pathways repeatedly appear:

1. Sleep and circadian disruption. Poor sleep changes cortisol, appetite, glucose control and food choice the next day.
2. Persistent high insulin. Like any repeated signal, constant exposure can reduce responsiveness.
3. Stress hormones. Cortisol and adrenaline raise available fuel. When stress becomes chronic, this can oppose insulin action.
4. Inflammation. Inflammatory signals can interfere with the internal steps that carry insulin’s message.
5. Energy overflow. When fat cells can no longer store energy safely, fats spill into liver, muscle and other tissues.
6. Low muscle demand. Inactive muscle requires less fuel and loses some of its capacity to clear glucose.

3. The Fat Cell: Storage Organ, Hormone Organ and Early Warning System

Body fat is not inert. Fat cells store energy, release hormones and communicate with the immune system. Healthy fat tissue can expand while keeping most stored energy safely contained. Trouble develops when individual fat cells become too large, poorly supplied with oxygen or unable to expand safely.

At that point, fat tissue may release more free fatty acids and inflammatory messengers. These signals reach the liver and muscle, where they can weaken insulin signalling. Certain fat-derived molecules, including ceramides, can disrupt the internal pathway that carries insulin’s instruction. In plain language, the hormone arrives, but the message is blocked inside the cell.

Why location matters

Subcutaneous fat sits under the skin. Visceral fat sits around internal organs. Visceral fat is more strongly linked with liver fat, inflammation, insulin resistance and cardiovascular risk. Therefore, waist change can carry more metabolic meaning than body weight alone.

However, appearance is not diagnosis. Some lean people store fat poorly and develop liver or organ fat at a low body weight. Conversely, some larger people retain relatively good glucose and lipid control for a time. This is why weight must be interpreted with waist, body composition, blood pressure, liver markers, lipids, glucose dynamics, fitness and personal risk.

The overflow model

1. Incoming energy repeatedly exceeds immediate demand.
2. Insulin directs more energy into storage and restrains fat release.
3. Fat cells enlarge; in susceptible people, safe storage capacity is reached.
4. Fatty acids and inflammatory signals increase in the bloodstream.
5. Liver and muscle accumulate fat-derived signals that interfere with insulin.
6. The pancreas compensates with more insulin, reinforcing the cycle.

4. The Insulin–Glucagon Balance

Glucagon is often described as insulin’s opposite. That is useful but incomplete. Insulin mainly signals that fuel is available and should be used or stored. Glucagon helps the liver release or create fuel when incoming energy is low. The balance between them helps determine whether the body is mainly storing energy or mobilising it.

After a carbohydrate-rich meal, insulin usually rises more strongly and glucagon is restrained. After protein, both can rise: insulin supports amino-acid use and tissue building, while glucagon helps prevent glucose from falling too far. During fasting or marked carbohydrate restriction, insulin falls and glucagon becomes relatively more influential, allowing greater fat release and ketone production.

Ketones: fuel and signal

Ketones are made mainly in the liver when insulin is low enough for fat mobilisation to increase. They provide fuel for the brain, heart and other tissues. They also act as signalling molecules that may influence inflammation, oxidative stress and cellular energy handling.

This does not mean higher ketones are always better. Nutritional ketosis is a controlled state with normal or mildly low glucose and modest ketone elevation. Diabetic ketoacidosis is a medical emergency caused by severe insulin deficiency, usually with very high glucose and acid build-up. The two states are physiologically different.

Practical interpretation

Metabolic improvement does not require everyone to pursue ketosis. The useful target is lower unnecessary insulin demand and better access to stored fat. Some people achieve this with a well-formulated low-carbohydrate pattern. Others improve with moderate carbohydrate reduction, better food quality, weight loss, exercise and longer gaps between meals.

5. Metabolic Health Across the Body

Insulin resistance is best viewed as a system-wide risk amplifier. It can influence many conditions, but it is rarely the only cause. Genetics, smoking, blood pressure, lipoproteins, infection, autoimmunity, environmental exposure, medication and ageing still matter.

Condition	Metabolic connection	What must still be assessed
Type 2 diabetes	Long compensation is followed by failure to keep glucose controlled.	Insulin demand, glucose pattern, pancreatic reserve, liver fat.
Cardiovascular disease	Insulin resistance clusters with high pressure, triglyceride-rich particles, inflammation and endothelial dysfunction.	ApoB, blood pressure, smoking, kidney function, inflammation and glucose control.
Fatty liver	The liver receives and makes more fat while export and oxidation become mismatched.	Waist, triglycerides, liver enzymes, imaging and alcohol intake.
Polycystic ovary syndrome	High insulin can amplify ovarian androgen production in susceptible women.	Cycles, androgens, glucose-insulin pattern, fertility goals.
Cognitive decline	Impaired vascular and brain energy handling may contribute to risk.	Blood pressure, lipids, sleep, activity, hearing, glucose and overall vascular risk.
Cancer	Insulin, glucose availability and inflammation may influence some tumour environments.	Cancer type, treatment, weight trajectory and oncology guidance.
Kidney disease	Diabetes, pressure and vascular dysfunction place stress on filtration.	eGFR, urine albumin, blood pressure and medication safety.

6. Measure Earlier, Measure the Pattern

No single test diagnoses whole-body metabolic health. Fasting insulin is useful, but assays vary and there is no universal cut-off that fits every laboratory or population. HOMA-IR combines fasting insulin and fasting glucose to estimate insulin resistance, but it is still an estimate, not a direct measurement.

Measure	What it adds	Main caution
Waist circumference / waist-to-height	Central fat and risk trend.	Track under the same conditions; direction matters.
Blood pressure	Vascular load and autonomic balance.	Use validated home readings, not one clinic value.
Fasting glucose	Overnight glucose control.	May remain normal during early compensation.
HbA1c	Approximate longer-term glucose exposure.	Can be distorted by red-cell and iron factors.
Fasting insulin	How hard the pancreas may be working at baseline.	Interpret with glucose, laboratory range and context.
HOMA-IR	Estimated fasting insulin resistance.	Useful for trends; not a direct clamp test.
Triglycerides and HDL	Fuel handling and a practical insulin-resistance pattern.	Medication, alcohol, fasting state and genetics matter.
ApoB / non-HDL cholesterol	Number or burden of atherogenic particles.	Essential for cardiovascular risk; do not dismiss when glucose improves.
ALT, GGT and imaging	Possible liver fat or liver stress.	Normal enzymes do not exclude fatty liver.
Urine albumin and eGFR	Early kidney stress and filtration.	Repeat abnormal results and interpret clinically.
Post-meal glucose or CGM	Dynamic response to meals, sleep, stress and movement.	Use patterns, not perfection or isolated spikes.
Strength and aerobic capacity	Functional metabolic reserve.	Performance is a health marker, not merely fitness.

A practical red-flag cluster

Concern rises when several of the following travel together: expanding waist, elevated blood pressure, high triglycerides, low HDL, raised fasting insulin or HOMA-IR, fatty liver, rising glucose, sleep apnoea, post-meal fatigue, strong hunger swings and declining fitness. One clue can be noise. A cluster is a story.

7. Food: Reduce Metabolic Pressure Without Creating Nutritional Debt

The first nutritional goal is to lower the amount and frequency of fuel the body cannot handle well. The second is to preserve muscle, micronutrients, fibre, enjoyment and long-term adherence.

The carbohydrate question

Carbohydrate raises glucose and insulin more directly than fat, while protein has a mixed and context-dependent effect. Therefore, reducing refined starches, sugars and liquid carbohydrates is often the highest-value first step. People with diabetes, fatty liver, high triglycerides, central obesity or large post-meal glucose rises may benefit from a larger reduction.

However, carbohydrate tolerance differs. A highly active, insulin-sensitive person may handle intact carbohydrate well. A sedentary person with central fat and fatty liver may not. The correct dose is the amount that supports stable energy, healthy markers, training, sleep and adherence.

A strong food hierarchy

1. Build each meal around protein. Protein supports muscle, recovery, satiety and healthy ageing.
2. Use non-starchy vegetables generously. They provide fibre, minerals and plant compounds with a low glucose load.
3. Choose fats mainly from minimally processed foods. Olive oil, nuts, seeds, eggs, fish and suitable dairy can support satiety and food quality.
4. Match carbohydrate to tolerance and activity. Prefer intact foods; reduce sugar, flour-based foods and refined snacks first.
5. Stop drinking energy. Sugary drinks, juices and frequent caloric beverages deliver fuel with little satiety.
6. Create meal boundaries. Three purposeful meals often produce less insulin exposure than continuous grazing.
7. Use the response. Waist, hunger, energy, glucose, lipids, liver markers and performance show whether the pattern works.

Do not replace one problem with another

A lower-carbohydrate diet can improve glucose, triglycerides, appetite and medication needs. Yet cardiovascular risk still requires direct attention. If ApoB or LDL-related particle burden rises substantially, the plan should be reviewed rather than dismissed. Food quality, fat sources, fibre, thyroid status, weight change, genetics and medication options may need attention.

8. Movement: Give Fuel Somewhere Useful to Go

Muscle is one of the body’s largest sites for glucose disposal. Contraction also helps muscle take up glucose through pathways that do not rely entirely on insulin. Therefore, movement is both treatment and prevention.

The minimum effective movement system

• Walk after meals. Even ten to fifteen minutes can reduce the size and duration of a post-meal glucose rise.
• Strength train. Progressive resistance preserves or builds the tissue that stores and uses glucose.
• Build an aerobic base. Regular moderate work improves mitochondrial capacity, circulation and fat use.
• Add intensity selectively. Brief vigorous intervals can improve fitness and insulin sensitivity, but only when recovery and cardiovascular safety allow.
• Break up sitting. Frequent short movement can matter even when formal exercise is already present.

The objective is not to “burn off” poor food choices. It is to build a body with greater fuel capacity and lower metabolic demand at rest.

9. Sleep, Stress and the Nervous System

Metabolic health is not only a food problem. Short or fragmented sleep can worsen insulin sensitivity within days. It also raises hunger, reduces restraint, changes food reward and makes exercise harder. Sleep apnoea adds repeated oxygen stress and is strongly linked with central obesity, high blood pressure and impaired glucose control.

Stress hormones make fuel available for action. This is useful during a short challenge. However, when pressure is continuous and recovery is weak, the same system can keep glucose higher, impair sleep, increase cravings and promote central fat storage.

A practical recovery sequence

1. Protect a consistent sleep window.
2. Get morning daylight and reduce bright light late at night.
3. Keep caffeine early enough that sleep is unaffected.
4. Use slow breathing to shift from threat mode toward recovery.
5. Separate demanding work from the final hour before bed.
6. Screen for snoring, witnessed pauses, morning headache and daytime sleepiness.

10. Fasting and Meal Timing

Fasting lowers incoming fuel and usually lowers insulin, allowing stored fat to become more available. Time-restricted eating can help some people reduce total intake, simplify decisions and improve glucose control. However, the benefit often comes from better structure and lower intake rather than from a unique clock effect alone.

Start with the least extreme tool that works: stop grazing, avoid late-night eating, create a twelve-hour overnight gap, and then extend only when energy, sleep, training and medication safety remain good.

Long fasts are not automatically superior. They can increase dizziness, overeating, sleep disruption or lean-mass loss in susceptible people. They require particular caution with diabetes medication, pregnancy, eating-disorder history, frailty, low body weight, kidney disease and demanding endurance training.

11. Medication and Clinical Safety

Lifestyle can change glucose and blood pressure quickly. Therefore, a strong metabolic plan must include medication awareness. Insulin, sulfonylureas and some other glucose-lowering drugs can cause hypoglycaemia when carbohydrate intake or meal frequency falls. Blood-pressure medication may also need review when pressure improves.

SGLT2 inhibitors require special caution with ketogenic diets or prolonged fasting because ketoacidosis can occur even without very high glucose. Medication must never be stopped or reduced casually. The prescriber should be involved before major dietary change when risk is present.

Likewise, metabolic improvement does not replace evidence-based cardiovascular treatment. A person with established cardiovascular disease still needs direct management of ApoB-containing particles, blood pressure, smoking, clotting risk, cardiac fitness and prescribed therapy.

12. My Coaching Method: From Data to Decisions

I help the client see the system that connects their history, symptoms, measurements, medication, food, movement, sleep, stress and recovery.

The process

1. Find the pattern. We identify where the control system is under strain and what may be compensation rather than health.
2. Prioritise the leverage points. We focus first on the few changes most likely to improve several outcomes at once.
3. Build the right plan. The plan matches health risk, preferences, travel, work pressure, family life and training.
4. Measure the response. We use symptoms, function and objective markers to decide what to keep, change or escalate.
5. Work with the medical team. Coaching strengthens informed conversations; it does not replace diagnosis or prescribing.

Questions I use to create clarity

1. Is glucose normal because metabolism is healthy, or because insulin is compensating?
2. Where is excess fuel being stored: safely under the skin, or increasingly in the liver and around organs?
3. Is muscle receiving enough demand, protein and recovery to remain a strong metabolic sink?
4. Are sleep and stress biology overriding a disciplined food plan?
5. Which marker represents immediate risk, and which represents the upstream driver?
6. What is the smallest change the client can repeat long enough to produce measurable evidence?

13. What the Evidence Does—and Does Not—Allow Us to Say

Strong evidence supports insulin resistance as a central feature of type 2 diabetes and a major part of metabolic syndrome, fatty liver and cardiovascular risk clustering. Strong evidence also supports weight reduction where appropriate, physical activity, resistance training, improved sleep, reduced refined carbohydrate intake and several dietary patterns for improving metabolic outcomes.

Low-carbohydrate and ketogenic diets can produce substantial short-term improvements in glucose control and triglycerides, and can reduce medication needs in type 2 diabetes. However, long-term superiority over other well-designed diets is less certain because adherence, food quality, weight loss and study design differ. Individual lipid responses also vary.

Mechanistic findings involving ketones, ceramides, inflammation and mitochondrial function are biologically important. Yet cell and animal findings cannot automatically be treated as proven clinical outcomes in humans. Similarly, an association between insulin resistance and a disease does not prove insulin resistance caused that disease in every person.

Therefore, the disciplined position is neither to minimise insulin nor to make it the answer to everything. It is to use insulin resistance as an early, actionable lens while maintaining full clinical risk assessment.

14. The Metabolic Health Checklist

Domain	Decision question
Energy regulation	Can you go several hours between meals without shaking, crashing or becoming preoccupied with food?
Body composition	Is waist stable or falling while strength and lean mass are protected?
Glucose control	Are fasting, HbA1c and post-meal patterns appropriate for your risk?
Insulin demand	Do fasting insulin, HOMA-IR or related patterns suggest the pancreas is overworking?
Lipid transport	Are triglycerides, HDL, non-HDL and ApoB moving in a safer direction?
Liver and kidney	Are liver fat risk, eGFR and urine albumin being checked when relevant?
Blood pressure	Are home readings controlled without dizziness or excessive medication burden?
Movement capacity	Are strength, aerobic fitness, balance and daily movement improving?
Recovery	Are sleep, stress response and nervous-system recovery supporting the plan?
Sustainability	Can this way of eating and living survive work, travel, family and ageing?

Final Thoughts

Metabolic decline often begins quietly. The body compensates, glucose appears acceptable and separate symptoms receive separate labels. Yet beneath them, the control system may be working progressively harder to manage fuel.

The opportunity is to act before compensation becomes disease. Reduce the fuel the body cannot handle. Build muscle that can use it. Restore sleep and recovery. Measure the pattern rather than one number. Then adjust the plan according to the response.

This is not a promise of perfect health. It is a practical route from hidden metabolic strain to clearer decisions, stronger function and more protected years of life.

About Mathew Gomes 

Functional Health Coach

Throughout my career, I learned that valuable assets are not just protected from failure. They are strengthened and expected to grow. Yet I treated my health differently.

In my late fifties, a heart attack and two stents changed that. Medical care saved my life, and medication gave me vital protection against another crisis.

But protection limits the downside. It does not build the asset.

So I trained in functional health and nutrition and combined it with executive coaching. Today, I help busy professionals connect their symptoms, test trends, medication, nutrition, sleep, stress, movement and recovery—then turn that complexity into clear priorities and a measurable plan.

Working alongside their doctors, we identify what is driving decline, rebuild function and grow their health asset—so they can extend their best years with energy, strength, clear thinking, independence and confidence.

I am a certified Functional Health and Nutrition Practitioner and an accredited Executive Coach with ICF and EMCC.

Disclaimer

This white paper is provided for educational and informational purposes only. It is not intended to diagnose, treat, cure, prevent, or provide medical advice for any disease or health condition.

The author is a Functional Health, Nutrition and Longevity Coach, not a medical doctor. The content presented reflects a functional, educational perspective on health, lifestyle, nutrition, and risk factors, and is designed to support informed self-care and productive conversations with qualified healthcare professionals. Nothing in this document should be interpreted as a substitute for medical advice, diagnosis, or treatment from a licensed physician or other qualified healthcare provider. Readers should not start, stop, or change any medication, supplement, or medical treatment without consulting their prescribing clinician.

Individual responses to nutrition, lifestyle, supplements, and coaching strategies vary. Any actions taken based on this information are done at the reader’s own discretion and responsibility. If you have a medical condition, are taking prescription medication, or have concerns about your health, you are advised to seek guidance from a licensed healthcare professional before making changes.